Intratympanic steroid treatments rescued recurrent hearing loss following COVID-19 vaccination and detection of an intralabyrinthine schwannoma

Weihang Li, Alan Micco, Deyu Fang*, Huiping Liu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

It remains unclear how to effectively treat rare cases of sudden and recurrent hearing losses which might coincidently follow vaccination. We report the first case, to our knowledge, of systemic and local steroid administration to successfully treat sudden and recurrent left-ear hearing loss, respectively, following a second dose of the BNT162b2 COVID-19 mRNA vaccination which inflammatory response potentially affected an existing left intralabyrinthine schwannoma in a young male patient. This case highlights the importance and timing of intratympanic steroid treatment strategies to suppress the progressive symptoms and restore hearing to a stable condition, and therefore avoid permanent hearing loss which would otherwise demand a surgical removal of the schwannoma to improve vertigo and reconstitute artificial hearing.

Original languageEnglish (US)
Article numbere249316
JournalBMJ case reports
Volume15
Issue number7
DOIs
StatePublished - Jul 1 2022

Keywords

  • Ear, nose and throat/otolaryngology
  • Oncology
  • Vaccination/immunisation

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Intratympanic steroid treatments rescued recurrent hearing loss following COVID-19 vaccination and detection of an intralabyrinthine schwannoma'. Together they form a unique fingerprint.

Cite this